Understanding the effects of genetic risk information for Alzheimer's in Latinos
Impacts of receiving Alzheimer's disease genetic risk information among Latinos in northern Manhattan
This study is looking at how sharing genetic risk information for late-onset Alzheimer's disease affects Latino individuals in northern Manhattan, helping us understand how it influences their mental health and behaviors over time.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10763041 on NIH RePORTER |
What this research studies
This research investigates how receiving genetic risk information for late-onset Alzheimer's disease affects Latinos in northern Manhattan. Participants will be randomly assigned to either receive information based on their ethnicity and family history or to receive additional details about their APOE genotype. The study will assess various psychosocial outcomes, memory performance, and health-related behaviors over time. Evaluations will occur at multiple points, allowing researchers to understand the long-term impacts of this information on participants' mental health and behavior.
Who could benefit from this research
Good fit: Ideal candidates for this research are Latino adults aged 21 and older who are interested in learning about their genetic risk for Alzheimer's disease.
Not a fit: Patients who are not Latino or those under 21 years old may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could help improve the way genetic risk information is communicated and understood, potentially leading to better health outcomes for patients at risk of Alzheimer's disease.
How similar studies have performed: Previous research has shown that providing genetic risk information can influence health behaviors and psychosocial outcomes, suggesting that this approach may yield valuable insights.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Ottman, Ruth — Columbia University Health Sciences
- Study coordinator: Ottman, Ruth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.